Eric Warren insider trades: Mineralys Therapeutics (MLYS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Eric reports to the SEC
Open-market buys and sales
31 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | MLYS | ↓ Sell | 7,438 | $28.12 | $209K | Direct | Sep 22, 2026 (1d) |
| Aug 21, 2026 | MLYS | ↓ Sell | 7,437 | $25.98 | $193K | Direct | Aug 25, 2026 (4d) |
| Jul 21, 2026 | MLYS | ↓ Sell | 7,438 | $26.87 | $200K | Direct | Jul 23, 2026 (2d) |
| Jun 26, 2026 | MLYS | ↓ Sell | 104,124 | $25.90 | $2.7M | Direct | Jun 30, 2026 (4d) |
| Apr 17, 2025 | ESPR | ↓ Sell | 108 | $0.98 | $106 | Direct | Apr 21, 2025 (4d) |
| Mar 18, 2025 | ESPR | ↓ Sell | 2,433 | $1.49 | $4K | Direct | Mar 19, 2025 (1d) |
| Feb 19, 2025 | ESPR | ↓ Sell | 239 | $1.87 | $446 | Direct | Feb 20, 2025 (1d) |
| Jan 17, 2025 | ESPR | ↓ Sell | 123 | $2.26 | $278 | Direct | Jan 21, 2025 (4d) |
| Dec 17, 2024 | ESPR | ↓ Sell | 2,234 | $2.43 | $5K | Direct | Dec 18, 2024 (1d) |
| Nov 19, 2024 | ESPR | ↓ Sell | 197 | $2.17 | $427 | Direct | Nov 20, 2024 (1d) |
| Oct 17, 2024 | ESPR | ↓ Sell | 107 | $2.12 | $227 | Direct | Oct 18, 2024 (1d) |
| Sep 17, 2024 | ESPR | ↓ Sell | 2,608 | $1.78 | $5K | Direct | Sep 18, 2024 (1d) |
| Aug 19, 2024 | ESPR | ↓ Sell | 211 | $1.95 | $411 | Direct | Aug 20, 2024 (1d) |
| Jul 17, 2024 | ESPR | ↓ Sell | 108 | $2.59 | $279 | Direct | Jul 19, 2024 (2d) |
| Jun 18, 2024 | ESPR | ↓ Sell | 2,540 | $2.86 | $7K | Direct | Jun 20, 2024 (2d) |
| May 17, 2024 | ESPR | ↓ Sell | 192 | $2.48 | $477 | Direct | May 20, 2024 (3d) |
| Sep 20, 2023 | ESPR | ↓ Sell | 742 | $1.25 | $924 | Direct | Sep 21, 2023 (1d) |
| Aug 18, 2023 | ESPR | ↓ Sell | 243 | $1.41 | $344 | Direct | Aug 21, 2023 (3d) |
| Jul 19, 2023 | ESPR | ↓ Sell | 106 | $1.58 | $168 | Direct | Jul 20, 2023 (1d) |
| Jun 21, 2023 | ESPR | ↓ Sell | 603 | $1.48 | $894 | Direct | Jun 22, 2023 (1d) |
| May 17, 2023 | ESPR | ↓ Sell | 219 | $1.62 | $356 | Direct | May 18, 2023 (1d) |
| Apr 19, 2023 | ESPR | ↓ Sell | 115 | $1.28 | $147 | Direct | Apr 20, 2023 (1d) |
| Mar 17, 2023 | ESPR | ↓ Sell | 526 | $1.78 | $937 | Direct | Mar 20, 2023 (3d) |
| Mar 7, 2023 | ESPR | ↓ Sell | 5,090 | $5.05 | $26K | Direct | Mar 8, 2023 (1d) |
| Oct 18, 2022 | ESPR | ↓ Sell | 107 | $7.69 | $823 | Direct | Oct 19, 2022 (1d) |
| Sep 19, 2022 | ESPR | ↓ Sell | 255 | $6.92 | $2K | Direct | Sep 20, 2022 (1d) |
| Aug 31, 2022 | ESPR | ↑ Buy | 1,000 | $7.46 | $7K | Direct | Aug 31, 2022 (0d) |
| Aug 17, 2022 | ESPR | ↓ Sell | 199 | $6.82 | $1K | Direct | Aug 18, 2022 (1d) |
| Jul 19, 2022 | ESPR | ↓ Sell | 431 | $6.58 | $3K | Direct | Jul 20, 2022 (1d) |
| Jun 17, 2022 | ESPR | ↓ Sell | 256 | $4.90 | $1K | Direct | Jun 21, 2022 (4d) |
| May 17, 2022 | ESPR | ↓ Sell | 196 | $5.98 | $1K | Direct | May 18, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MLYS insiders
Open-market trades in the last 12 months
About Eric Warren's insider trades
Eric Warren is Chief Commercial Officer at Mineralys Therapeutics (MLYS). Since May 17, 2022, Eric has reported 1 open-market purchase worth $7K and 30 sales worth $3.4M on SEC Form 4. In the last 12 months: 4 sales ($3.3M).
Their filings also include grants and awards (5 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MLYS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.